Viewing nowCombinationNewbicar Tablet 10/40mg
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daehan Newpharm Co., Ltd.

MFDS item code 201601778 · Approved 2016.04.04 · Insurance code 669906680
Treatment of essential hypertension not controlled with monotherapy
This medication is used to help control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with either amlodipine or olmesartan medoxomil. It assists in effectively managing hypertension, thereby reducing the risk of cardiovascular complications. Such treatment contributes to lowering blood pressure reliably and improving patient health. Therefore, this medication is used in the treatment of essential hypertension.
Take 1 tablet once daily with water, with or without food. It is recommended that the medication be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose of each individual component (amlodipine or olmesartan medoxomil) be adjusted before starting this medication; however, switching directly to this medication may be considered if blood pressure is not adequately controlled with monotherapy using either component. The maximum dose of this medication is 10/40 mg. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The recommended doses are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or olmesartan medoxomil 20 mg. - 10/20 mg: For patients whose blood pressure is not adequately controlled with monotherapy using olmesartan medoxomil 20 mg. - 5/40 mg: For patients whose blood pressure is not adequately controlled with 5/20 mg. - 10/40 mg: For patients whose blood pressure is not adequately controlled with 5/40 mg. ○ Patients with renal impairment: This medication has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil for patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 mg once daily. Use of this medication is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ○ Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. ○ Patients with hepatic impairment: Use caution when administering this medication to patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 mg once daily, and the maximum dose is 20 mg once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics. This medication should not be administered to patients with severe hepatic impairment. (See section 2, “Patients who should not receive this medication,” under Precautions for Use.) ○ Older adults: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in older adults.
Under 18 years of age: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Those who are allergic to the active ingredients of this medication or similar drugs, those who are pregnant or breastfeeding, and individuals with severe liver disease or specific heart valve diseases should not take this medication. Patients with reduced body fluids or sodium may experience symptoms of hypotension, so careful monitoring is needed when starting treatment. Acute hypotension due to vasodilation may occur rarely, so caution is needed for patients with aortic stenosis. In severe heart disease patients, symptoms may worsen upon drug administration, thus caution is advised. Patients with poor kidney function should undergo regular kidney function tests, as this medication may affect the kidneys. Patients with decreased liver function may have slower metabolism of this medication, possibly requiring dosage adjustments. This medication can cause various side effects, and common ones may include dizziness, headache, decreased blood pressure, gastrointestinal disturbances, skin rash, etc. It is important to consult a doctor immediately if serious side effects are suspected. This medication may interact with other antihypertensive drugs or some medications, so it is essential to inform the healthcare provider of any other prescriptions being taken. Avoid taking this medication with grapefruit juice, as it may intensify its effects. It is generally advised not to take this medication during pregnancy, and if planning to become pregnant or during pregnancy, it is essential to consult a doctor. In breastfeeding, this medication may be transmitted through breast milk and could impact the baby, so consultation with a doctor about stopping breastfeeding or medication is necessary. Children under 18 years old should not use this medication as its safety and efficacy in this age group have not been established. Older adults may experience different effects and side effects of the medication due to decreased kidney and liver function. Starting with a lower dose and closely monitoring the condition is advised. In case of overdose, blood pressure may drop too low and heart rate may increase, requiring immediate medical attention for appropriate treatment. This medication should be stored in a closed container, protected from direct sunlight and moisture, out of reach of children, and it is best not to transfer it to a different container.
Drug hypersensitivity, hyperkalemia, decreased libido, dizziness, headache, orthostatic hypotension, drowsiness, paresthesia, sensory reduction, syncope, vertigo, palpitations, rapid pulse, hypotension, orthostatic hypotension, dyspnea, cough, nausea, vomiting, dyspepsia, diarrhea, constipation, dry mouth, upper abdominal pain, rash, urticaria, muscle tension, limb pain, low back pain, polyuria, erectile dysfunction, peripheral edema, edema, pitting edema, fatigue, weakness, facial edema, decreased serum potassium, increased serum creatinine, increased serum uric acid, increased gamma-glutamyl transferase, decreased hemoglobin and hematocrit, cholelithiasis, female breast neoplasm, exacerbation of cerebral infarction, gum bleeding, orthostatic dizziness, chest pain, cold, increased CRP, fever, hemoptysis, excessive sneezing, runny nose, laryngitis, arthritis, flank pain, generalized pain, hypoglycemia, weight loss, heartburn, gastroenteritis, herpes zoster, double vision, weakness, angioedema, chronic malabsorption syndrome - similar intestinal disease, intestinal vascular edema, rhabdomyolysis, acute renal failure, hair loss, itching, autoimmune hepatitis, elevated serum creatinine, leukopenia, thrombocytopenia, toxic epidermal necrolysis, flushing, fatigue, edema, palpitations, dizziness, headache, drowsiness, abdominal pain, nausea, gynecomastia, jaundice, elevated liver enzymes, hypotension, tachycardia, bradycardia, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is essential to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps to preserve the medication's efficacy.
Brownish-red round film-coated tablets
30 tablets/box [10 tablets/Alu-Alu*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daehan Newpharm Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.